Psyence Biomedical Ltd (NASDAQ: PBM) Recovers 13.25% From 52-Week Low, Is PBM Still A High-Risk, High-Reward Play?

Psyence Biomedical Ltd (NASDAQ:PBM) currently has a daily average trading volume of 2.52M but it saw 2412513 shares traded in last market. With a market cap of 5.86M USD, the company’s current market price of $1.71 came rising about 2.40 while comparing to the previous closing price of $1.67. In past 52 weeks, the stock remained buoying in the range of price level as high as $584.25 and as low as $1.51. In the recent trading on the day, stock has struck highest price mark of $1.61 while lowest mark touched by it was $2.1798.

Taking a look at 20-day trading activity of Psyence Biomedical Ltd (PBM) gives us an average price of $1.9650, while its current price level is -99.71% below from 52-week high level whereas it is 13.25% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $2.6973 while that of 200 days or SMA-200 reads an average of $27.2969. A closer look into the stock’s movement over the week reveals that its volatility is standing at 13.48% during that period while stretching the period over a month that increases to 15.52%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 38.43 which implies that the stock is in neutral territory.

Over the week, PBM’s stock price is moving 4.27% up while it is -30.49% when we observe its performance for the past one month. Year-to-date it is -18.96% down and over the past year, the stock is showing a downside performance of -99.68%.

The company is expected to be releasing its next quarterly report in February, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.

Currently, Psyence Biomedical Ltd’s total number of outstanding shares is 0.72M with 2.75% of that held by the insiders while 9.42% of its common stock has been owned by the institutions. Stock’s beta reads -0.48.